文献速递乳腺外科围术期管理与 ERAS

预测老年乳腺癌患者术后并发症及其对生活质量和功能状态的影响

Predicting postoperative complications and their impact on quality of life and functional status in older patients with breast cancer.
PubMed 文献 · Br J Surg · 2022-01-01

本研究基于2013—2018年接受手术的≥70岁Tis-3 N0乳腺癌女性,开发并外部验证了术后30天并发症预测模型(5个预测因子,内部AUC 0.76,外部AUC 0.70)。校正混杂因素后,术后并发症未影响术后第一年的功能状态和生活质量。手术仍是多数老年乳腺癌患者的标准治疗。

要点

  • 预测模型含年龄、多重用药、BMI、乳腺手术类型和腋窝手术类型5个因子。
  • 模型内部验证AUC 0.76(95%CI 0.72–0.80),外部验证AUC 0.70(95%CI 0.68–0.72)。
  • 校正混杂因素后,术后并发症未影响术后第一年功能状态和生活质量。

核心结论

  • 该验证后的预测模型可用于老年乳腺癌患者术后咨询。
  • 术后并发症未影响术后第一年的功能状态和生活质量,即使校正预设混杂因素后亦然。
  • 手术仍是多数老年乳腺癌患者的标准治疗。

研究设计与样本

  • 开发队列纳入2013—2018年接受手术的≥70岁Tis-3 N0乳腺癌女性547例。
  • 外部验证使用英国Bridging the Age Gap研究数据,纳入2727例女性。
  • 采用多变量logistic回归开发预测模型,线性混合模型评估功能状态和生活质量变化。

主要发现

  • 预测模型由5个预测因子组成:年龄、多重用药、BMI、乳腺手术类型和腋窝手术类型。
  • 模型内部验证AUC 0.76(95%CI 0.72–0.80),外部验证AUC 0.70(95%CI 0.68–0.72)。
  • 校正混杂因素后,术后并发症与功能状态和生活质量无关联。

关键数值与推荐

  • 预测模型包含5个预测因子:年龄、多重用药、BMI、乳腺手术类型和腋窝手术类型。
  • 内部验证AUC 0.76(95%CI 0.72–0.80),外部验证AUC 0.70(95%CI 0.68–0.72)。
  • 功能状态采用Groningen Activity Restriction Scale评估,生活质量采用EORTC QLQ-C30和QLQ-BR23问卷评估。

临床怎么用

  • 可用该预测模型向老年乳腺癌患者告知术后并发症风险,辅助手术决策咨询。
  • 术后并发症不应作为老年乳腺癌患者功能状态和生活质量下降的预期理由。
  • 对多数老年乳腺癌患者,手术仍应作为标准治疗选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The percentage of older patients undergoing surgery for early-stage breast cancer has decreased over the past decade. This study aimed to develop a prediction model for postoperative complications to better inform patients about the benefits and risks of surgery, and to investigate the association between complications and functional status and quality of life (QoL). METHODS: Women aged at least 70 years who underwent surgery for Tis-3 N0 breast cancer were included between 2013 and 2018. The primary outcome was any postoperative complication within 30 days after surgery. Secondary outcomes included functional status and QoL during the first year after surgery, as assessed by the Groningen Activity Restriction Scale and the European Organisation for Research and Treatment of Cancer QLQ-C30 and QLQ-BR23 questionnaires. A prediction model was developed using multivariable logistic regression and validated externally using data from the British Bridging the Age Gap Study. Linear mixed models were used to assess QoL and functional status over time. RESULTS: The development and validation cohorts included 547 and 2727 women respectively. The prediction model consisted of five predictors (age, polypharmacy, BMI, and type of breast and axillary surgery) and performed well in internal (area under curve (AUC) 0.76, 95 per cent c.i. 0.72 to 0.80) and external (AUC 0.70, 0.68 to 0.72) validations. Functional status and QoL were not affected by postoperative complication after adjustment for confounders. CONCLUSION: This validated prediction model can be used to counsel older patients with breast cancer about the postoperative phase. Postoperative complications did not affect functional status nor QoL within the first year after surgery even after adjustment for predefined confounders. Surgery remains the standard of care for the majority of older patients with breast cancer. The percentage of older patients with breast cancer receiving surgery is decreasing. The reason for this decline is unknown, but it might be due to fear of complications. To better inform patients about the benefits and risks of surgery, the aim of this study was to develop a prediction model for complications after surgery. Another important aspect, especially for older adults with breast cancer, is quality of life, functional capacity, and ability to carry out daily tasks (functional status) after therapy. This study showed that quality of life and functional status did not decline after breast surgery, irrespective of the occurrence of postoperative complications.

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. Lemij AA, van der Plas-Krijgsman WG, Bastiaannet E, et al. Predicting postoperative complications and their impact on quality of life and functional status in older patients with breast cancer. Br J Surg. 2022. PMID: 35470383. doi:10.1093/bjs/znac014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。